Free Trial
NASDAQ:VRPX

Virpax Pharmaceuticals (VRPX) Stock Price, News & Analysis

Virpax Pharmaceuticals logo
$0.35 +0.02 (+7.15%)
As of 07/11/2025 03:47 PM Eastern

About Virpax Pharmaceuticals Stock (NASDAQ:VRPX)

Key Stats

Today's Range
$0.33
$0.36
50-Day Range
$0.22
$0.46
52-Week Range
$0.13
$60.25
Volume
11,248 shs
Average Volume
155,316 shs
Market Capitalization
$439.17 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$75.00
Consensus Rating
Hold

Company Overview

Virpax Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
30th Percentile Overall Score

VRPX MarketRank™: 

Virpax Pharmaceuticals scored higher than 30% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Virpax Pharmaceuticals has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Virpax Pharmaceuticals has received no research coverage in the past 90 days.

  • Read more about Virpax Pharmaceuticals' stock forecast and price target.
  • Price to Book Value per Share Ratio

    Virpax Pharmaceuticals has a P/B Ratio of 0.21. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.79% of the float of Virpax Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Virpax Pharmaceuticals has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Virpax Pharmaceuticals has recently increased by 18.15%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Virpax Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    Virpax Pharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.79% of the float of Virpax Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Virpax Pharmaceuticals has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Virpax Pharmaceuticals has recently increased by 18.15%, indicating that investor sentiment is decreasing significantly.
    • Insider Buying vs. Insider Selling

      In the past three months, Virpax Pharmaceuticals insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      Only 3.70% of the stock of Virpax Pharmaceuticals is held by insiders.

    • Percentage Held by Institutions

      Only 32.23% of the stock of Virpax Pharmaceuticals is held by institutions.

    • Read more about Virpax Pharmaceuticals' insider trading history.
    Receive VRPX Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

    VRPX Stock News Headlines

    Virpax Pharmaceuticals Inc trading halted, news pending
    Utah’s New Oil Find
    The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle of the Utah's Black Desert. Why? Not for oil discovery. Or uranium or solar. Instead, what’s happening beneath this patch of sand is the discovery of a new kind of energy. Google, Buffett, and a even tech billionaires like Gates, Bezos, and Zuckerberg are grabbing a stake.
    Virpax receives positive Probudur results for dose range study
    Virpax Pharmaceuticals announces 1-for-25 reverse stock split
    See More Headlines

    VRPX Stock Analysis - Frequently Asked Questions

    Virpax Pharmaceuticals' stock was trading at $9.4975 at the start of the year. Since then, VRPX shares have decreased by 96.3% and is now trading at $0.3536.

    Virpax Pharmaceuticals shares reverse split before market open on Friday, March 1st 2024.The 1-10 reverse split was announced on Friday, March 1st 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, March 1st 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

    Virpax Pharmaceuticals (VRPX) raised $15 million in an IPO on Wednesday, February 17th 2021. The company issued 1,400,000 shares at a price of $10.00-$12.00 per share. ThinkEquity (a division of Fordham Financial Management) served as the underwriter for the IPO.

    Shares of VRPX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Virpax Pharmaceuticals investors own include AMC Entertainment (AMC), Dare Bioscience (DARE), Rallybio (RLYB), Mullen Automotive (MULN), Plug Power (PLUG), SNDL (SNDL) and SOS (SOS).

    Company Calendar

    Today
    7/11/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    Pharmaceutical preparations
    Sub-Industry
    Pharmaceutical Products
    Current Symbol
    NASDAQ:VRPX
    CIK
    1708331
    Fax
    N/A
    Employees
    7
    Year Founded
    N/A

    Price Target and Rating

    High Price Target
    $75.00
    Low Price Target
    $75.00
    Potential Upside/Downside
    +21,958.8%
    Consensus Rating
    Hold
    Rating Score (0-4)
    2.00
    Research Coverage
    1 Analysts

    Profitability

    EPS (Trailing Twelve Months)
    N/A
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    -$15.19 million
    Net Margins
    N/A
    Pretax Margin
    N/A
    Return on Equity
    -1,554.34%
    Return on Assets
    -338.29%

    Debt

    Debt-to-Equity Ratio
    N/A
    Current Ratio
    0.13
    Quick Ratio
    0.13

    Sales & Book Value

    Annual Sales
    N/A
    Price / Sales
    N/A
    Cash Flow
    N/A
    Price / Cash Flow
    N/A
    Book Value
    $1.65 per share
    Price / Book
    0.21

    Miscellaneous

    Outstanding Shares
    1,242,000
    Free Float
    4,707,000
    Market Cap
    $422.28 thousand
    Optionable
    Not Optionable
    Beta
    1.58
    The Best High-Yield Dividend Stocks for 2025 Cover

    Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

    Get This Free Report

    This page (NASDAQ:VRPX) was last updated on 7/12/2025 by MarketBeat.com Staff
    From Our Partners